Bayer Aktienges Ads (BAYRY) 136.4100 $BAYRY
Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles
M2 - 1 hr 25 mins ago
Research and Markets (http://www.researchandmarkets.com/research/3xpp5q/renal_anemia) has announced the addition of the "Renal Anemia - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Renal Anemia and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Hospira, Inc. - Medgenics Inc. - Amgen Inc. - GlaxoSmithKline plc - Daiichi Sankyo Company, Limited - FibroGen, Inc. - Japan Tobacco Inc. - Zydus Cadila Healthcare Limited - Bayer AG - 3SBio Inc. - ProMetic Life Sciences Inc. - JCR Pharmaceuticals Co., Ltd. - CCM Duopharma Biotech Bhd. - Panacea Biotec Limited - Affymax, Inc. - Myungmoon pharmaceutical Co.,Ltd. - Intas Pharmaceuticals Ltd. - Acceleron Pharma, Inc. - Pieris AG - Noxxon Pharma AG - Aprogen, Inc. - Dong-A Socio Group Drug Profiles - peginesatide - darbepoetin alfa - epoetin - epoetin alfa - Peg-EPO - roxadustat - sotatercept - GSK-1278863 - lexaptepid pegol - molidustat - MDGN-201 - PEG-EPO - FG-2216 - PRS-080 - epoetin alfa - JTZ-951 - epoetin alfa - DS-1093 - NuPIAO - PBI-1402 - PBI-4050 - ZP-EPO - darbepoetin alfa - MM-P01-01 - Recombinant Protein for Renal Anemia For more information visit http://www.researchandmarkets.com/research/3x...nal_anemia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Market for Polycarbonate - Forecast, Trends & Opportunities 2014-2020
M2 - 1 hr 54 mins ago
Research and Markets (http://www.researchandmarkets.com/research/5ltdpp/global_market_for) has announced the addition of the "Global Market for Polycarbonate - Forecast, Trends & Opportunities 2014-2020" report to their offering. The global demand for polycarbonate is likely to cross 6,000,000 tons by 2020, while the production of polycarbonates is expected to reach nearly 5,000,000 tons by 2020. Polycarbonates are a particular group of thermoplastic polymers that are generally known by the trademarked names like Makrolon, Makroclear, arcoPlus, Lexan, etc. Polycarbonates have a unique property that they can be easily molded and thermoformed and they are easy to work with as well. These properties have made polycarbonates quite attractive an option for many industries ranging from automobiles, electronics and electricals, opticals, amongst others. Optical media remains one of the principal applications of polycarbonates. The global market for polycarbonates is expected to show good growth in the coming years. The global polycarbonate market was dominated by the Asia Pacific region. North America and Europe followed next as well. The Asia Pacific region accounted for more than 60% of the demand for polycarbonates in the world. In the Asia Pacific region, China accounted for nearly 60% of the polycarbonate demand and was also the largest polycarbonate consumer globally. Investors have now shifted focus on building up the polycarbonate capacity in the Middle East & Africa region. The MEA region is now expanding as a polycarbonate manufacturing hub primarily due to the easy availability of low cost feedstock in the region. By 2020, the MEA region is expected to establish itself as a major exporter of polycarbonate. Key Topics Covered: 1. Executive Summary 2. Introduction To Polycarbonates 3. Global Market For Polycarbonate 4. Global Polycarbonate Market: Analysis By Regions 5. Global Polycarbonate Market: Analysis Of Key Markets 6. Impacts On The Global Polycarbonate Market 7. Global Polycarbonate Market: Competitive Landscape & Major Players - Asahi Kasei Corporation - Bayer AG - Chi Mei Corporation - Formosa Plastics Group - Honam Petrochemical Corporation (now Lotte Chemical Corporation) - Idemitsu Kosan Co., Ltd. - LG Chem Ltd - Mitsubishi Chemical Holdings Corporation - Mitsubishi Engineering-Plastics Corporation - Mitsubishi Gas Chemical Co - Samsung Petrochemical Co., Ltd. - Samyang Corporation - Saudi Basic Industries Corporation - Shanghai Chlor-Alkali Chemical Co., Ltd - Teijin Limited - The Dow Chemical Company - Unigel Plasticos SA For more information visit http://www.researchandmarkets.com/research/5l...market_for
The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 06, 8:23AM CDT
Source: Anthony Easton via Flickr . If you're anything like me, walking down the first-aid aisle in the grocery store or drugstore creates a deer in the headlights look nearly every time. The amount of over-the-counter therapeutics that consumers...
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 2:12PM CDT
The Dow had a lacklustre week after weakness in energy shares and a series of other concerns dampened investor sentiment.
Bayer Discloses Encouraging Data on Anticoagulant Xarelto - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 4:10PM CDT
Bayer (BAYRY) announced encouraging results from the X-VeRT study on Xarelto.
Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 5:30PM CDT
Bayer (BAYRY) and Johnson & Johnson (JNJ) announced that they will be evaluating Xarelto in three new indications.
Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 8:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdwv9t/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices. Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates. The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications. Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period.The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment. The report showcases top players such as: - Abbot Laboratories - Roche Diagnostics - Siemens - Johnson & Johnson - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Sysmex Corp KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others For more information visit http://www.researchandmarkets.com/research/sd...l_in_vitro
Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG
PR Newswire - Tue Sep 02, 7:00AM CDT
Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more complete portfolio of solutions to treat challenging vascular conditions.
OncoMed's Vantictumab Studies' Partial Clinical Hold Lifted - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:50PM CDT
OncoMed Pharmaceuticals, Inc. (OMED) announced that the FDA has removed the partial clinical hold on the enrollment process in the phase I studies on vantictumab.
Biomaterials Global Market Research - Forecasts to 2020
M2 - Thu Aug 28, 4:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ndz7fx/biomaterials) has announced the addition of the "Biomaterials Global Market - Forecast to 2020" report to their offering. The global biomaterials market is expected to reach around $90 billion by 2017 growing at a CAGR of more than 15.0% The technological advancements, rise in investments, grants and funding by governing bodies, research related activities and vast application areas are some of the major drivers for biomaterials market. Whereas, rigid regulatory systems, reimbursement concerns, inflammatory reactions, and fracture issues are some of the restraints that are hindering the biomaterial market growth. Across the globe biomaterial market is expected to view a surplus of opportunities due to new developments in the fields of ophthalmology, neurology, tissue engineering, and increase in cardiac patients. The global biomaterials market is dominated by North America followed by Europe. The favorable reimbursements by Centers for Medicare and Medicaid Services (CMS) and rising investments by the U.S. government are attributing to the North American market growth. While Asia Pacific region is expected to grow at a faster rate due to increase in bone graft substitutes fueled by the rapidly expanding elderly population, and a high incidence of orthopedic disorders. Key Topics Covered: 1. EXECUTIVE SUMMARY 2. Introduction 3. Market Analysis 4. Biomaterial Market by Material 5. Biomaterial Market by Application 6. Geographic Analysis 7. Competitive Landscape 8. Company Profiles - Basf SE - Bayer AG - Berkeley Advanced Biomaterials, Inc - Cam Bioceramics BV - Carpenter Technology Corporation - Evonik Industries AG - Heraeus Medical Components, Inc. (Subsidiary Of Heraeus Holding Gmbh) - Landec Corporation - Wright Medical Group, Inc. - Sigma-Aldrich Corporation For more information visit http://www.researchandmarkets.com/research/nd...omaterials
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:55PM CDT
Bristol-Myers (BMY) and partner Pfizer (PFE) announced that the FDA has cleared Eliquis for an additional indication.
Automotive Adhesives - Global Strategic Business Report 2013-2020
M2 - Fri Aug 22, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7629fs/automotive) has announced the addition of the "Automotive Adhesives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Automotive Adhesives in US$ Million by the following Product Segments: The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. The report profiles 57 companies including many key and niche players such as: - 3M Company - Arkema Group - Ashland, Inc. - BASF SE - Bayer AG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Noteworthy Trends, Growth Drivers & Issues 3. Product Overview 4. Product Introductions/Innovations 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 57 (including Divisions/Subsidiaries 65) - The United States (44) - Japan (4) Europe (11) - France (2) - Germany (4) - The United Kingdom (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (6) For more information visit http://www.researchandmarkets.com/research/7629fs/automotive
Global Superabsorbent Polymers (Sodium Polyacrylate, Polyacrylamide Copolymer and Others) Market 2014 - 2020
M2 - Fri Aug 22, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m64wh3/superabsorbent) has announced the addition of the "Superabsorbent Polymers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. 'Superabsorbent Polymers Market (Sodium Polyacrylate, Polyacrylamide Copolymer and Others) for Baby Diapers, Adult Incontinence Products, Feminine Hygiene Products and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020' Superabsorbent polymers (SAP) help keep the skin dry, thereby preventing the spread of infections in diaper users. Demand for these polymers is expected to be high in the near future. There are two types of superabsorbent polymers (SAP): sodium polyacrylate and polyacrylamide copolymer. Both these polymers are used in the manufacture of diapers and various hygiene products in the market. The market for superabsorbent polymers (SAP) is anticipated to grow significantly due to increasing demand for hygiene products. This study analyzes, estimates, and forecasts the global superabsorbent polymers (SAP) market from the demand perspective in terms of volume (Kilo tons) and revenue (USD million) from 2014 to 2020. The report also analyzes several market drivers and restraints along with their impact on the market during the forecast period. The report provides a detailed view of superabsorbent polymers (SAP) market by analyzing the key segments of products and applications. Application segments in the superabsorbent polymers (SAP) market include baby diapers, adult incontinence products, feminine hygiene products and others. The report also provides an analysis of each product and application segment and forecasts the market in terms of volume and revenue from 2014 to 2020. Additionally, it segments the market based on key geographies including North America, Europe, Asia Pacific and Rest of the World. The superabsorbent polymers (SAP) report further provides market volume and revenue for each product and application segment under each regional segment. Based on the applications of superabsorbent polymers (SAP), the report analyzes the attractiveness of each segment using the attractiveness tool. The study includes a value chain for better understanding of key players, right from raw material manufacturers to end-users. The study on superabsorbent polymers (SAP) also offers a comprehensive view of the market using Porter's five forces analysis. Report Scope Superabsorbent Polymers (SAP) Market - Product Segment Analysis - Sodium polyacrylate - Polyacrylamide copolymer - Others (Ethylene-maleic anhydride copolymer, polyvinyl alcohol copolymers, etc.) Superabsorbent Polymers (SAP) Market - Application Analysis - Baby diapers - Adult incontinence products - Feminine hygiene products - Others (Paper packaging, medical, agriculture, etc.) Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Superabsorbent Polymer (SAP) Market: Industry Analysis Chapter 4 Superabsorbent Polymer (SAP) Market - Product Segment Analysis Chapter 5 Superabsorbent Polymer (SAP) Market - Application Segment Analysis Chapter 6 Superabsorbent Polymer (SAP) Market - Regional Segment Analysis Chapter 7 Company profiles - BASF SE - Bayer AG - Evonik Industries AG - Formosa Plastics Group - LG Chem Ltd. - Mitsubishi Chemical Holdings Corp. - NIPPON SHOKUBAI Co., Ltd. - SDP Global Co. Ltd. - SUMITOMO SEIKA CHEMICALS Co., Ltd. - Sinopec Group For more information visit http://www.researchandmarkets.com/research/m6...rabsorbent
Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk
M2 - Wed Aug 20, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6xznb6/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" report to their offering. Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to function by using bio-identical hormones. The therapy contains estrogen and progesterone, and in some cases testosterone, to reduce symptoms of menopause. This replacement therapy may also protect against osteoporosis, reduce the risk of coronary heart disease, and may prevent or delay the onset of Alzheimer's disease. Replacement therapy can also increase the chance of developing more serious health complications such as blood clots, breast cancer, uterine cancer, and bowel cancer. The analysts forecast the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period 2013-2018. The Global Hormone Replacement Therapy market can be divided into three segments: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Type of Therapy 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned: - Actavis plc - Bayer AG - Merck & Co. Inc. - Novartis AG - Novo Nordisk A/S - Abbott Laboratories Ltd. - Amgen Inc. - ANI Pharmaceuticals Inc. - Hisamitsu Pharmaceutical Co. Inc. - MylanLaboratories Inc. - Orion Corp. - QuatRx Pharmaceuticals Co. - Teva Pharmaceutical Industries Ltd. - TherapeuticsMD Inc. For more information visit http://www.researchandmarkets.com/research/6x...al_hormone
A New Cannabinoid-based Arthritis Therapy in the Making
ACCESSWIRE - Tue Aug 19, 8:50AM CDT
WHITEFISH, MT / August 19, 2014 / Cannabinoids have been the focus of intense clinical research following the legalization of medical cannabis by several U.S. states. While pioneers like British-based GW Pharmaceuticals plc (NASDAQ: GWPH) have been actively studying cannabinoids since the 1990s, many North American companies haven't started major research until recent years with compounds just starting clinical trials.
Sinopharm, Biostar, Lilly Rise on Medical Modernization in China
at The Street - Mon Aug 18, 1:11PM CDT
Pharmaceutical companies are profiting from China’s urban ailments and a growing appetite for western-style medicinal treatments
Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles
M2 - 1 hr 25 mins ago
Research and Markets (http://www.researchandmarkets.com/research/3xpp5q/renal_anemia) has announced the addition of the "Renal Anemia - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Renal Anemia and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Hospira, Inc. - Medgenics Inc. - Amgen Inc. - GlaxoSmithKline plc - Daiichi Sankyo Company, Limited - FibroGen, Inc. - Japan Tobacco Inc. - Zydus Cadila Healthcare Limited - Bayer AG - 3SBio Inc. - ProMetic Life Sciences Inc. - JCR Pharmaceuticals Co., Ltd. - CCM Duopharma Biotech Bhd. - Panacea Biotec Limited - Affymax, Inc. - Myungmoon pharmaceutical Co.,Ltd. - Intas Pharmaceuticals Ltd. - Acceleron Pharma, Inc. - Pieris AG - Noxxon Pharma AG - Aprogen, Inc. - Dong-A Socio Group Drug Profiles - peginesatide - darbepoetin alfa - epoetin - epoetin alfa - Peg-EPO - roxadustat - sotatercept - GSK-1278863 - lexaptepid pegol - molidustat - MDGN-201 - PEG-EPO - FG-2216 - PRS-080 - epoetin alfa - JTZ-951 - epoetin alfa - DS-1093 - NuPIAO - PBI-1402 - PBI-4050 - ZP-EPO - darbepoetin alfa - MM-P01-01 - Recombinant Protein for Renal Anemia For more information visit http://www.researchandmarkets.com/research/3x...nal_anemia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Market for Polycarbonate - Forecast, Trends & Opportunities 2014-2020
M2 - 1 hr 54 mins ago
Research and Markets (http://www.researchandmarkets.com/research/5ltdpp/global_market_for) has announced the addition of the "Global Market for Polycarbonate - Forecast, Trends & Opportunities 2014-2020" report to their offering. The global demand for polycarbonate is likely to cross 6,000,000 tons by 2020, while the production of polycarbonates is expected to reach nearly 5,000,000 tons by 2020. Polycarbonates are a particular group of thermoplastic polymers that are generally known by the trademarked names like Makrolon, Makroclear, arcoPlus, Lexan, etc. Polycarbonates have a unique property that they can be easily molded and thermoformed and they are easy to work with as well. These properties have made polycarbonates quite attractive an option for many industries ranging from automobiles, electronics and electricals, opticals, amongst others. Optical media remains one of the principal applications of polycarbonates. The global market for polycarbonates is expected to show good growth in the coming years. The global polycarbonate market was dominated by the Asia Pacific region. North America and Europe followed next as well. The Asia Pacific region accounted for more than 60% of the demand for polycarbonates in the world. In the Asia Pacific region, China accounted for nearly 60% of the polycarbonate demand and was also the largest polycarbonate consumer globally. Investors have now shifted focus on building up the polycarbonate capacity in the Middle East & Africa region. The MEA region is now expanding as a polycarbonate manufacturing hub primarily due to the easy availability of low cost feedstock in the region. By 2020, the MEA region is expected to establish itself as a major exporter of polycarbonate. Key Topics Covered: 1. Executive Summary 2. Introduction To Polycarbonates 3. Global Market For Polycarbonate 4. Global Polycarbonate Market: Analysis By Regions 5. Global Polycarbonate Market: Analysis Of Key Markets 6. Impacts On The Global Polycarbonate Market 7. Global Polycarbonate Market: Competitive Landscape & Major Players - Asahi Kasei Corporation - Bayer AG - Chi Mei Corporation - Formosa Plastics Group - Honam Petrochemical Corporation (now Lotte Chemical Corporation) - Idemitsu Kosan Co., Ltd. - LG Chem Ltd - Mitsubishi Chemical Holdings Corporation - Mitsubishi Engineering-Plastics Corporation - Mitsubishi Gas Chemical Co - Samsung Petrochemical Co., Ltd. - Samyang Corporation - Saudi Basic Industries Corporation - Shanghai Chlor-Alkali Chemical Co., Ltd - Teijin Limited - The Dow Chemical Company - Unigel Plasticos SA For more information visit http://www.researchandmarkets.com/research/5l...market_for
The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 06, 8:23AM CDT
Source: Anthony Easton via Flickr . If you're anything like me, walking down the first-aid aisle in the grocery store or drugstore creates a deer in the headlights look nearly every time. The amount of over-the-counter therapeutics that consumers...
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 2:12PM CDT
The Dow had a lacklustre week after weakness in energy shares and a series of other concerns dampened investor sentiment.
Bayer Discloses Encouraging Data on Anticoagulant Xarelto - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 4:10PM CDT
Bayer (BAYRY) announced encouraging results from the X-VeRT study on Xarelto.
Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 5:30PM CDT
Bayer (BAYRY) and Johnson & Johnson (JNJ) announced that they will be evaluating Xarelto in three new indications.
Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 8:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdwv9t/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices. Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates. The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications. Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period.The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment. The report showcases top players such as: - Abbot Laboratories - Roche Diagnostics - Siemens - Johnson & Johnson - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Sysmex Corp KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others For more information visit http://www.researchandmarkets.com/research/sd...l_in_vitro
Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG
PR Newswire - Tue Sep 02, 7:00AM CDT
Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more complete portfolio of solutions to treat challenging vascular conditions.
OncoMed's Vantictumab Studies' Partial Clinical Hold Lifted - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:50PM CDT
OncoMed Pharmaceuticals, Inc. (OMED) announced that the FDA has removed the partial clinical hold on the enrollment process in the phase I studies on vantictumab.
Biomaterials Global Market Research - Forecasts to 2020
M2 - Thu Aug 28, 4:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ndz7fx/biomaterials) has announced the addition of the "Biomaterials Global Market - Forecast to 2020" report to their offering. The global biomaterials market is expected to reach around $90 billion by 2017 growing at a CAGR of more than 15.0% The technological advancements, rise in investments, grants and funding by governing bodies, research related activities and vast application areas are some of the major drivers for biomaterials market. Whereas, rigid regulatory systems, reimbursement concerns, inflammatory reactions, and fracture issues are some of the restraints that are hindering the biomaterial market growth. Across the globe biomaterial market is expected to view a surplus of opportunities due to new developments in the fields of ophthalmology, neurology, tissue engineering, and increase in cardiac patients. The global biomaterials market is dominated by North America followed by Europe. The favorable reimbursements by Centers for Medicare and Medicaid Services (CMS) and rising investments by the U.S. government are attributing to the North American market growth. While Asia Pacific region is expected to grow at a faster rate due to increase in bone graft substitutes fueled by the rapidly expanding elderly population, and a high incidence of orthopedic disorders. Key Topics Covered: 1. EXECUTIVE SUMMARY 2. Introduction 3. Market Analysis 4. Biomaterial Market by Material 5. Biomaterial Market by Application 6. Geographic Analysis 7. Competitive Landscape 8. Company Profiles - Basf SE - Bayer AG - Berkeley Advanced Biomaterials, Inc - Cam Bioceramics BV - Carpenter Technology Corporation - Evonik Industries AG - Heraeus Medical Components, Inc. (Subsidiary Of Heraeus Holding Gmbh) - Landec Corporation - Wright Medical Group, Inc. - Sigma-Aldrich Corporation For more information visit http://www.researchandmarkets.com/research/nd...omaterials
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Zacks Analyst Interviews
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:55PM CDT
Bristol-Myers (BMY) and partner Pfizer (PFE) announced that the FDA has cleared Eliquis for an additional indication.
Automotive Adhesives - Global Strategic Business Report 2013-2020
M2 - Fri Aug 22, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7629fs/automotive) has announced the addition of the "Automotive Adhesives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Automotive Adhesives in US$ Million by the following Product Segments: The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. The report profiles 57 companies including many key and niche players such as: - 3M Company - Arkema Group - Ashland, Inc. - BASF SE - Bayer AG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Noteworthy Trends, Growth Drivers & Issues 3. Product Overview 4. Product Introductions/Innovations 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 57 (including Divisions/Subsidiaries 65) - The United States (44) - Japan (4) Europe (11) - France (2) - Germany (4) - The United Kingdom (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (6) For more information visit http://www.researchandmarkets.com/research/7629fs/automotive
Global Superabsorbent Polymers (Sodium Polyacrylate, Polyacrylamide Copolymer and Others) Market 2014 - 2020
M2 - Fri Aug 22, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m64wh3/superabsorbent) has announced the addition of the "Superabsorbent Polymers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. 'Superabsorbent Polymers Market (Sodium Polyacrylate, Polyacrylamide Copolymer and Others) for Baby Diapers, Adult Incontinence Products, Feminine Hygiene Products and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020' Superabsorbent polymers (SAP) help keep the skin dry, thereby preventing the spread of infections in diaper users. Demand for these polymers is expected to be high in the near future. There are two types of superabsorbent polymers (SAP): sodium polyacrylate and polyacrylamide copolymer. Both these polymers are used in the manufacture of diapers and various hygiene products in the market. The market for superabsorbent polymers (SAP) is anticipated to grow significantly due to increasing demand for hygiene products. This study analyzes, estimates, and forecasts the global superabsorbent polymers (SAP) market from the demand perspective in terms of volume (Kilo tons) and revenue (USD million) from 2014 to 2020. The report also analyzes several market drivers and restraints along with their impact on the market during the forecast period. The report provides a detailed view of superabsorbent polymers (SAP) market by analyzing the key segments of products and applications. Application segments in the superabsorbent polymers (SAP) market include baby diapers, adult incontinence products, feminine hygiene products and others. The report also provides an analysis of each product and application segment and forecasts the market in terms of volume and revenue from 2014 to 2020. Additionally, it segments the market based on key geographies including North America, Europe, Asia Pacific and Rest of the World. The superabsorbent polymers (SAP) report further provides market volume and revenue for each product and application segment under each regional segment. Based on the applications of superabsorbent polymers (SAP), the report analyzes the attractiveness of each segment using the attractiveness tool. The study includes a value chain for better understanding of key players, right from raw material manufacturers to end-users. The study on superabsorbent polymers (SAP) also offers a comprehensive view of the market using Porter's five forces analysis. Report Scope Superabsorbent Polymers (SAP) Market - Product Segment Analysis - Sodium polyacrylate - Polyacrylamide copolymer - Others (Ethylene-maleic anhydride copolymer, polyvinyl alcohol copolymers, etc.) Superabsorbent Polymers (SAP) Market - Application Analysis - Baby diapers - Adult incontinence products - Feminine hygiene products - Others (Paper packaging, medical, agriculture, etc.) Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Superabsorbent Polymer (SAP) Market: Industry Analysis Chapter 4 Superabsorbent Polymer (SAP) Market - Product Segment Analysis Chapter 5 Superabsorbent Polymer (SAP) Market - Application Segment Analysis Chapter 6 Superabsorbent Polymer (SAP) Market - Regional Segment Analysis Chapter 7 Company profiles - BASF SE - Bayer AG - Evonik Industries AG - Formosa Plastics Group - LG Chem Ltd. - Mitsubishi Chemical Holdings Corp. - NIPPON SHOKUBAI Co., Ltd. - SDP Global Co. Ltd. - SUMITOMO SEIKA CHEMICALS Co., Ltd. - Sinopec Group For more information visit http://www.researchandmarkets.com/research/m6...rabsorbent
Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk
M2 - Wed Aug 20, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6xznb6/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" report to their offering. Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to function by using bio-identical hormones. The therapy contains estrogen and progesterone, and in some cases testosterone, to reduce symptoms of menopause. This replacement therapy may also protect against osteoporosis, reduce the risk of coronary heart disease, and may prevent or delay the onset of Alzheimer's disease. Replacement therapy can also increase the chance of developing more serious health complications such as blood clots, breast cancer, uterine cancer, and bowel cancer. The analysts forecast the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period 2013-2018. The Global Hormone Replacement Therapy market can be divided into three segments: Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, and Thyroid Hormone Replacement Therapy. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Type of Therapy 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned: - Actavis plc - Bayer AG - Merck & Co. Inc. - Novartis AG - Novo Nordisk A/S - Abbott Laboratories Ltd. - Amgen Inc. - ANI Pharmaceuticals Inc. - Hisamitsu Pharmaceutical Co. Inc. - MylanLaboratories Inc. - Orion Corp. - QuatRx Pharmaceuticals Co. - Teva Pharmaceutical Industries Ltd. - TherapeuticsMD Inc. For more information visit http://www.researchandmarkets.com/research/6x...al_hormone
A New Cannabinoid-based Arthritis Therapy in the Making
ACCESSWIRE - Tue Aug 19, 8:50AM CDT
WHITEFISH, MT / August 19, 2014 / Cannabinoids have been the focus of intense clinical research following the legalization of medical cannabis by several U.S. states. While pioneers like British-based GW Pharmaceuticals plc (NASDAQ: GWPH) have been actively studying cannabinoids since the 1990s, many North American companies haven't started major research until recent years with compounds just starting clinical trials.
Sinopharm, Biostar, Lilly Rise on Medical Modernization in China
at The Street - Mon Aug 18, 1:11PM CDT
Pharmaceutical companies are profiting from China’s urban ailments and a growing appetite for western-style medicinal treatments
